


Neuroendocrine Neoplasms (NEN) – genetic related syndromes

Genetics and Neuroendocrine Tumors

A spotlight on Multiple Endocrine Neoplasia (MEN)

Medullary thyroid cancer is a rare form of thyroid cancer. The term medullary describes the type of cells in the thyroid gland affected by the cancer. The majority of patients with medullary thyroid cancer (approximately 80%) have no family history of the condition; the remaining 20% of patients inherit the condition from a parent (thus the disease is ‘familial’). Familial medullary thyroid cancer is inherited in a dominant way, which means a patient with the gene mutation for medullary thyroid cancer will have a 50% chance of passing it on to their offspring.
The inherited form of medullary thyroid cancer is associated with three conditions: familial medullary thyroid cancer, multiple endocrine neoplasia type 2A (MEN2A) and multiple endocrine neoplasia type 2B (MEN2B). Both multiple endocrine neoplasia (MEN) syndromes are characterised by the presence of other diseases in addition to medullary thyroid cancer.
Familial medullary thyroid cancer is caused by a mutation in a gene called “Rearranged during Transfection” (RET) proto-oncogene.